4.7 Article

The Detection of Acute HIV Infection

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 202, 期 -, 页码 S270-S277

出版社

OXFORD UNIV PRESS
DOI: 10.1086/655651

关键词

-

资金

  1. University of North Carolina Center for AIDS Research [5 P30 AI50410]
  2. National Institutes of Health (NIH) HIV Prevention Trials Network [5 U01 AI069518]
  3. Center for HIV Vaccine Immunology [5 U01 AI067854, 5 R37 DK049381]
  4. National Institute of Allergy and Infectious Diseases [P01 AI071713]
  5. Abbott Laboratories
  6. Tibotec Therapeutics
  7. Bristol-Myers Squibb
  8. Gilead Sciences
  9. Office of AIDS Research, National Institutes of Health

向作者/读者索取更多资源

Acute human immunodeficiency virus (HIV) infection (AHI) can be defined as the time from HIV acquisition until seroconversion. Incident HIV infection is less well defined but comprises the time from the acquisition of HIV (acute infection) through seroconversion (early or primary HIV infection) and the following months until infection has been well established, as characterized by a stable HIV viral load (viral load set point) and evolution of antibodies with increased concentration and affinity for HIV antigens. During AHI, a viral latent pool reservoir develops, the immune system suffers irreparable damage, and the infected (often unsuspecting) host may be most contagious. It has proved very difficult to find individuals with AHI either in longitudinal cohorts of subjects at high risk for acquiring the virus or through cross-sectional screening, and the opportunity for diagnosis is generally missed during this phase. We review the technical strategies for identifying individuals with acute or incident HIV infection. We conclude that further technical advances are essential to allow more widespread detection of patients with AHI and to affect HIV treatment outcomes and transmission prevention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据